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Abstract 15 
Studying polysaccharide-protein interactions under physiological conditions by 16 
conventional techniques is challenging. Ideally, macromolecules could be followed by both 17 
in vitro spectroscopy experiments as well as in tissues using microscopy, to enable a 18 
proper comparison of results over these different scales but, often, this is not feasible. The 19 
cell surface and extracellular matrix polysaccharides, glycosaminoglycans (GAGs) lack 20 
groups that can be detected selectively in the biological milieu. The introduction of 19F 21 
labels into GAG polysaccharides is explored and the interaction of a labelled GAG with the 22 
heparin-binding protein, antithrombin, employing 19F NMR spectroscopy is followed. 23 
Furthermore, the ability of 19F labelled GAGs to be imaged using CARS microscopy is 24 
demonstrated. 19F labelled GAGs enable both 19F NMR protein-GAG binding studies in 25 
solution at the molecular level and non-linear microscopy at a microscopic scale to be 26 
conducted on the same material, essentially free of background signals. 27 
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Introduction 30 
An understanding of the biological processes that determine cell-cell signalling, hence coordinate 31 
cellular responses and maintain healthy growth and development, must encompass a detailed 32 
appreciation of interactions between proteins and extracellular matrix (ECM) polysaccharides [1-3]. 33 
Moreover, the network of interactions that defines healthy homeostasis is also relevant to disease 34 
processes, many of which involve some modification to this network [1]. One practical challenge is 35 
how to study phenomena, particularly interactions, that correlate with natural or disease processes, 36 
but which range in scale from the dimensions of molecules to the macroscopic level of tissues and 37 
organisms. Current approaches at the molecular level include spectroscopic and crystallographic 38 
techniques, which allow investigation at the level of ensembles of molecules, while various forms of 39 
(mainly) optical microscopy allow tissues to be examined in detail at the macroscopic level. 40 
However, few techniques or tools have the ability to work across these scales. Each approach also 41 
tends to employ distinct and largely incompatible labelling procedures and detection techniques, 42 
hence, it can be difficult to interpret them together, or extrapolate results from one technique to the 43 
other and, consequently, to relate the observations to the biological processes under investigation. 44 
Clearly, it would be advantageous if it were possible to utilise the same materials throughout. 45 
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 Studying interactions between proteins and polysaccharides in solution presents a number 46 
of further challenges. There are several reasons why conventional techniques for the detailed 47 
study of proteins, either in the solid state employing crystallography, or in solution using NMR, are 48 
often unsuitable when the protein to be studied is bound to a polysaccharide ligand. First, it is not 49 
usually possible to crystallise a protein in the presence of a polysaccharide and, especially in the 50 
case of extracellular polysaccharides such as the glycosaminoglycans (GAGs), the polysaccharide 51 
is frequently a complex and heterogeneous mixture of sequences and chain dimensions. The 52 
problem has been managed in several crystallographic and NMR studies by employing short 53 
oligosaccharide fragments acting as proxies for their parent polysaccharide and this has revealed 54 
some structural details of their interactions [4-7]. The use of oligosaccharide fragments as a stand-55 
in for the polysaccharide is widespread, although there are differences in binding properties which 56 
have their origins in the distinct conformational and motional behaviour of oligo- compared to 57 
polysaccharides but, possibly, also in the different numbers of potential binding sites in the two 58 
cases [8]. In the case of 1H and 13C NMR, the size and low mobility of protein-polysaccharide 59 
complexes in solution can lead to line broadening. Additional techniques with which to follow the 60 
interactions between proteins and GAGs are therefore required. One possibility is solid state NMR, 61 
which has been used to obtain detailed information in aggregates consisting of peptides and GAGs 62 
[9,10] but, it would also be desirable to be able to follow the location of GAGs in tissues by 63 
microscopy. One family of emerging techniques, based on Raman Spectroscopy, involves the 64 
selective observation of chemical groups that are particular to the molecules of interest. 65 
Unfortunately, there are no obvious Raman signals which are unique to GAGs. Their characteristic 66 
carboxylate, amine, acetyl and sulfate groups are also present to some extent in other biological 67 
molecules. With these considerations in mind, we have sought a label which has desirable 68 
characteristics both in terms of sensitivity in microscopy and NMR, exhibits very low or no 69 
background signal in biological systems and that can be informative as regards changes in its 70 
environment. The 19F nucleus fulfils many of these criteria and here, we investigate the possibility 71 
of employing 19F labelling of GAG poly- and oligosaccharides as a route to unambiguous 72 
information concerning protein-polysaccharide interactions using NMR spectroscopy, and as a 73 
potential means of following events in tissues employing non-linear (CARS) microscopy.  74 
The 19F nucleus constitutes 100% of the fluorine occurring naturally and, with nuclear spin 75 
½, presents readily-interpretable NMR signals, which are sensitive to the surrounding chemical 76 
environment owing to the lone pair electrons in the outer shell of the 19F atom. A strong 77 
paramagnetic component dominates the chemical shift and, usefully, also provides good signal 78 
dispersion. 19F NMR spectra in biological systems are very clean since almost no 19F is present in 79 
biology naturally [11] and is particularly useful in systems whose size, immobility and/or complexity 80 
precludes conventional NMR approaches, such as transmembrane proteins and macromolecular 81 
complexes. The sensitivity of the 19F nucleus to its immediate environment, including to solvent 82 
water or deuterium oxide (in D2O compared to D2O/H2O 80:20, v/v, Δδ = 0.13 ppm), also makes it 83 
suitable for studies involving site-specific labelling, denaturation experiments [12] and for 84 
identifying interactions at protein interfaces. In addition, the temperature dependence of 19F NMR 85 
signal line widths renders it sensitive to mobility, from which information relating to both binding 86 
and stability can be deduced. Although not investigated here, the chemistry employed to introduce 87 
19F into biomolecules is also suitable for 18F, opening-up the possibility of conducting positron 88 
emission tomography (PET). Labelling of proteins with 18F [13], as well as of sugars during their 89 
chemical synthesis has been reported [14,15] and the chemical labelling of amino acid side chains 90 
with fluorine via a range of amino acid side chains (aliphatic, aromatic and cysteine) has also been 91 
achieved [16]. Such labels can have effects on the structure of the protein however, and one 92 
approach that has been explored to minimise this problem is to conduct partial substitution [17,18]. 93 
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The attachment of suitable 19F containing groups to glycosaminoglycan (GAG) 94 
polysaccharides would extend many of the advantages exploited for proteins to the GAG class of 95 
molecules, thereby opening-up the study of polysaccharide-protein interactions. The choice of label 96 
made here; N-trifluoroacetyl, which is readily introduced to free amino groups of glucosamine 97 
residues within the polysaccharide chains, and trifluoroalkylamines, (either 2,2,2-98 
trifluoroethylamine (TFEA) or 3,3,3 trifluoropropylamine (TFPA)), which can be introduced through 99 
amide formation onto the former carboxylate groups of uronic acids via the 1-ethyl-3(3-100 
dimethylaminopropyl) carbodiimide (EDC)-activated ester, both contain a terminal -CF3 group. 101 
These provide a clean signal in 19F NMR, owing to short T1 relaxation times and low chemical shift 102 
anisotropy but, usefully, also provide distinct Raman transitions, exploitable in coherent Anti-103 
Stokes Raman Scattering (CARS) and other, non-linear microscopy techniques. Signals arising 104 
from C-F bond stretching are also unambiguous, there being effectively no background signals. 105 
Labelling GAG macromolecules with 19F using -CF3 groups can therefore provide both a suitable 106 
NMR signal with favourable spectroscopic properties capable of providing information regarding 107 
molecular interactions in vitro, but also in tissues [12], as well as a signal that can be used in non-108 
linear microscopy (such as CARS), which is free of background and interference from water, 109 
allowing direct chemical imaging. Two straightforward methods of introducing 19F into GAG 110 
polysaccharides (denoted (i) and (ii) below) are reported. Illustrative examples of their use as 111 
probes of molecular interactions in solution using 19F NMR spectroscopy and the ability to image 112 
them using CARS microscopy are demonstrated. 113 
Methods 114 
(i) Preparation of trifluoroacetylated glycosaminoglycan polysaccharides (1):- The first procedure is 115 
based on O-acylation using acetic anhydride, in which iodine has been proposed to act as a Lewis 116 
acid catalyst [19]. The free amino groups of glucosamine residues in heparin (used widely as an 117 
experimental proxy for the more scarce, naturally occurring ligand, heparan sulfate) polysaccharide 118 
derivatives, in which free amino groups had been introduced [20], was labelled selectively using 119 
trifluoroacetic anhydride with iodine as catalyst. With this class of large, anionic polysaccharides, 120 
however, the reaction was found to be highly selective for the free amino groups of the 121 
glucosamine residues of the polysaccharides, forming trifluoroacetamido-derivatives. De-N-122 
sulfated heparin polysaccharide (25 mg, ~40 µmol of disaccharide equivalents) was added as a 123 
solid to trifluoroacetic anhydride (9.5 mmol), with solid iodine flakes (0.2 mmol) and stirred at room 124 
temperature. The reactants were then precipitated in ice-cold ethanol (200 mL) and filtered, 125 
washed with ethanol, any large iodine grains were removed and the filtrate was washed until any 126 
remaining iodine had been removed (brown colour subsides: n.b. iodine in the wash was 127 
neutralised by the addition of solid sodium metabisulfite until a clear iodide containing solution had 128 
been obtained and was then disposed of). The recovered GAG compounds; N-trifluoroacetyl 129 
heparin (1) was dialysed (7 kDa cut-off dialysis membrane (SpectraPore, USA)) 3 times against 2 130 
L of distilled water, the dialysate was recovered, then subjected to gel permeation chromatography 131 
(Sephadex G-25) and characterised by 19F [Table 1] and 13C NMR spectroscopy [Supp. Fig. 1] 132 
prior to being employed in experiments.  133 
(ii) Introduction of trifluoroalkyl groups at carboxylate groups of uronic acids of heparin and the 134 
heparin-derived pentasaccharide, ArixtraTM, via EDC activation (2), (3) and (4):- The second 135 
method involved attachment of the 19F label via the carboxylate groups of uronate residues in 136 
GAGs. The carboxylate groups were activated using 1-ethyl-3-(3-dimethylaminopropyl) 137 
carbodiimide (EDC, Pearce) in 50 mM HEPES buffer and the resulting EDC ester reacted with an 138 
alkylamine; either 2,2,2 trifluoethylamine (TFEA) or 3,3,3 trifluoropropylamine (TFPA), both 139 
convenient water soluble fluoroamines, of moderate volatility (b.p. 36-37 and 67.5-68 °C 140 
respectively), to form the corresponding fluoroamides. [Note: - If EDC is added before the 141 
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alkylamine to the GAG solution, a side-product persists, evident in 13C and 1H NMR, thought to 142 
originate from a rearrangement of the isourea adduct [21]. This provides an alternative labelling 143 
method, acting specifically on the carboxylate groups of the uronic acids. The method was applied 144 
to both GAG polysaccharides (described in (a) below) and to the pentasaccharide antithrombotic 145 
drug ArixtraTM, whose systematic name, [α-D-Glucopyranoside, methyl O-2- deoxy-6-O-sulfo-2-146 
(sulfoamino) -α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-deoxy-3,6-di-O-147 
sulfo -2-(sulfoamino)-α-D-glucopyranosyl-(1→4)- O-2-O-sulfo-α-L- idopyranuronosyl- (1→4) -2-148 
deoxy-2-(sulfoamino)-6-(hydrogen sulfate), sodium salt], is abbreviated to ‘AGAIA’, and described 149 
in (b).  150 
(a). Derivatisation of Ido-2-de-sulfated heparin and heparin with TFEA (2) and (3):- The ido-2-de-O-151 
sulfated porcine mucosal heparin20 (for the preparation of (2)) or porcine mucosal heparin (for the 152 
preparation of (3)) (25 mg) was dissolved in 50 mM HEPES buffer (0.50 mL, pH 6.8), TFEA (61 153 
µmol) added, followed by EDC (26 µmol). The reaction mixture was then stirred at room 154 
temperature (30 mins) and the products ((2) or (3)) were dialysed (7 kDa cut-off dialysis membrane 155 
(SpectraPore, USA)) 3 times against 2 L of distilled water, the dialysate recovered, subjected to gel 156 
permeation chromatography (Sephadex G-25) and employed in experiments.     157 
 158 
(b). Derivatisation of AGAIA pentasaccharide with TFPA (4):- The pentasaccharide, AGAIA 159 
(ArixtraTM) (2.5. mg, 1.7 umol in 0.5 mL 137 mM NaCl) was mixed with HEPES buffer (0.5 mL, 50 160 
mM, pH 6.8) and TFPA (2 µL, 22 µmol) were added, followed by EDC (1 mg, 5.2 µmol) and shaken 161 
for 10 mins at room temperature. The products were then desalted by gel permeation 162 
chromatography using Sephadex G-25, freeze dried and characterised by 19F NMR (Table 1) 163 
before being employed in binding experiments. 164 
 165 
(iii). 19F NMR investigation of GAG interaction with antithrombin in solution:- Decoupled 19F NMR 166 
experiments were conducted on a Bruker Avance III 500 MHz spectrometer (UNICAMP, Instituto 167 
de Quimica, Campinas, Brazil) using antithrombin (AT; 100 µL, 15 mg/mL in PBS containing D2O) 168 
and additions of (4), (500 µL, 1 mg/mL) or heparin (500 µL, 5 mg/mL) [Fig. 1]. 169 
(iv). Selective Detection of 19F labelled heparin-derived polysaccharides using Non-linear (CARS) 170 
Microscopy:- The form of Raman microscopy used here is based on a non-linear Raman technique 171 
termed coherent anti-Stokes Raman scattering (CARS). This technique can generate coherent 172 
signals up to 105 times stronger than conventional Raman and relies on the use of light as a pump 173 
to alter the populations of vibrational states, then to probe, providing anti-Stokes light emission of 174 
higher energy (i.e. lower wavelength) than that of the pump [22]. The 19F labelled heparin 175 
derivatives (1) to (3) were used in CARS Raman microscopy experiments, in which the Raman 176 
signal from the CF3 group provided a means of detecting selectively a film of the polysaccharide by 177 
means of its CARS signal [Fig. 2]. 178 
Results and Discussion 179 
The fluorinated products were first characterised by 19F NMR to provide a range of 180 
complementary probes, suitable for GAG-protein interactions studies and non-linear spectroscopy 181 
[Table 1]. The reaction was also applied to the antithrombin (AT) binding pentasaccharide, 182 
(AGAIA) and was found, surprisingly, to label selectively the GlcA carboxylate group [Supp. Fig. 183 
2]. This product was then shown by 19F NMR spectroscopy to bind AT in solution [Fig. 1A; lower 184 
panel (unbound) and middle panel (bound)] by virtue of a change in chemical shift position 185 
downfield of unreacted TFPA and binding was confirmed using fluorescence shift assay [Fig. 1B]. 186 
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The binding of (4) to AT in solution was then disrupted by the addition of excess unlabelled heparin 187 
[Fig. 1A; upper panel]. Furthermore, the 19F labelled AGAIA pentasaccharide was able to stabilise 188 
AT to an extent comparable to the unmodified form [Fig. 1B] confirming its interaction with 189 
antithrombin [23].  190 
Images (1.16 mm x 1.16 mm) were recorded in the forward CARS (F-CARS) mode on a 191 
Leica TSC-SP8 CARS instrument (Wetzler, Germany), employing pump lasers (the first pump 192 
laser selected at 928.2 nm and the second CARS laser, fixed, at 1064.5 nm) both at 46 % power. 193 
Images, detected at 1379 cm-1 pre-determined to offer useful C-F derived Raman signals [23] were 194 
recorded at 0.05 frames/s with 1.20 µs dwell time per pixel, a gain of 850.82 V and at 10 x 195 
magnification. Five µL of compounds (1), (2) and (3) were dried from solutions (1 mg/mL in H2O) 196 
on a glass slide and imaged [Fig. 2A, 2B and 2C]. As a control, the second laser (1064.5 nm) was 197 
then switched-off and no image was observed, confirming that the images were CARS-derived 198 
(Fig. 2D).  199 
Both methods of labelling heparin and other GAG derivatives are suitable for conducting NMR and 200 
microscopy studies and this will allow the same reagent to be used to examine events on scales 201 
ranging from those of molecules to tissues, providing more readily interpretable data. There are 202 
many other types of selective labelling that could be exploited to allow 19F NMR and non-linear 203 
microscopy with other classes of macromolecules, such as proteins. One example would be to 204 
incorporate 19F labelled Trp residues, which can be achieved biosynthetically through either 5- or 205 
6- fluorouridine. In this way, it will also be possible to follow proteins in tissues and the GAG 206 
polysaccharides with which they interact, as well as to study exactly the same interactions in vitro 207 
using 19F NMR. One interesting finding was that, in contrast to the situation observed for heparin 208 
polysaccharides, the reaction of TFPA with the pentasaccharide, AGAIA, did provide highly 209 
selective reaction with the carboxylate group of the GlcA residue over those of IdoA [Supp. Fig. 2] 210 
perhaps reflecting its more accessible, equatorial conformation. The use of CARS microscopy to 211 
study molecular interactions in tissues is in its infancy but, promises to be able to investigate 212 
complex assemblies by virtue of its ability to selectively observe a range of chemical groups, 213 
whether they be naturally occurring, or have been introduced deliberately. This paper proposes a 214 
number of 19F-labelled GAG probes which can also be used in both NMR and CARS microscopy 215 
applications. 216 
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 324 
Figures and Tables 325 
 326 
 327 
 328 
 329 
 330 
 331 
 332 
 333 
 334 
 335 
 336 
Figure 1. 19F labelled GAGs can be used as probes of protein binding and of solution 337 
environment. 19F NMR spectra of: A. (lower) 19F-labelled AGAIA pentasaccharide (4) alone, 338 
(middle) bound 19F-labelled AGAIA pentasaccharide in the presence of antithrombin (AT) and 19F-339 
labelled AGAIA pentasaccharide in the presence of antithrombin plus added heparin to compete-340 
off the ligand, (upper) returning to a distinct chemical shift position, demonstrating the sensitivity of 341 
the 19F label to the solution environment. B. Differential scanning fluorimetry showing that the 19F 342 
labelled AGAIA pentasaccharide (4) stabilised AT (red curve, compared to AT alone, blue curve) to 343 
an extent comparable to the unlabelled pentasaccharide (gold curve). 344 
345 
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 346 
 347 
 348 
 349 
 350 
 351 
 352 
 353 
 354 
 355 
 356 
 357 
 358 
 359 
Figure 2. CARS images of dried films of 19F labelled GAG (heparin) derivatives. A. Compound 360 
(1), B. Compound (2), C. Compound (3), D. Control experiment with the 1064.5 nm CARS laser 361 
switched-off, showing no image and confirming that the images in A-C are derived from CARS. 362 
Images were recorded at 10 x magnification and correspond to a field size of 1.16 mm x 1.16 mm.  363 
 364 
Table 1. 19F NMR chemical shifts for (1) to (4). 365 
 366 
Name      Compound   δ 19F /ppm 367 
N-Trifluoroacetyl porcine mucosal heparin  (1)  -75.58a 368 
Trifluorethylamido-Ido-2-de-O-sulfated heparin  (2)  -72.2a 369 
Trifluorethylamido-heparin    (3)  -72.3a 370 
AGAIA (ArixtraTM pentasaccharide)   (4)  -64.8b 371 
a. Recorded at 298 K on a 500 MHz Bruker Avance III HD NMR spectrometer with 5-mm BBO probe. Chemical 372 
shift values reported relative to TFA in D2O at (δ 19F), -75.61ppm. The chemical shift of (1) was also measured for 373 
a range of temperatures from 288 to 333 K, showing good linearity (Data not shown). 374 
b. Recorded at 300 K relative to trifluoroethylamine (TFEA) at  (δ 19F), -65.12 ppm.  375 
 376 
 377 
 378 
 379 
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 381 
 382 
Supplementary Figure 1 383 
 384 
Supp. Fig. 1. 13C NMR spectrum of N-trifluoracetyl heparin (1) at 50 C in D2O/H2O 385 
 386 
Supplementary Figure 2 387 
 388 
 389 
 390 
 391 
 392 
 393 
 394 
 395 
 396 
 397 
Supp. Fig. 2. 1H NMR spectra of AGAIA (bottom) and AGAIA-CF3 (top) at 30 ºC in D2O 398 
